SpecStream

Data / Form D filings / HCW Biologics Inc.

HCW Biologics Inc.: Form D filing

HCW Biologics Inc., a biotechnology company in Miramar, FL, filed a Form D with the SEC in 2026. The latest, on October 8, 2026, reports $1.5 million sold of a $1.5 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Get filings like this oneWeekly RSS feed

Company details from the filing

Address
2929 N. Commerce Parkway, Miramar, FL, 33025
Phone
(954) 842-2024
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1828673

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 8New notice$1,500,000$1,500,0001Sep 24sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Hing WongExecutive Officer, Director
Rebecca ByamExecutive Officer
Peter RhodeExecutive Officer
Scott GarrettDirector
Rick GreeneDirector
Lisa GilesDirector
Lee FlowersExecutive Officer

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Oct 5 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what HCW Biologics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.